Haller Julia A — SEC insider filings

SEC reporting owner CIK 1656082. 35 insider filings on record with FilingPulse; latest filed 2026-11-06.

Transaction summary — filings shown

Covers all 35 filings on record, filed 2020-10-02 to 2026-11-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
BRISTOL MYERS SQUIBB CO (BMY)Director25—1 leg · 3,800 sh · $240,57828
Outlook Therapeutics, Inc. (OTLK)Director7——10
EYENOVIA, INC. (EYEN)Director3——6

Insider filings — Haller Julia A

FiledFormIssuerReported transactionsSource
2026-11-064BRISTOL MYERS SQUIBB CO (BMY)Sale (S): 3,800 @ $63.31EDGAR
2026-06-164BRISTOL MYERS SQUIBB CO (BMY)Option exercise (M): 20,460 @ $53.76 · Option exercise (M): 20,460 (derivative) @ $0EDGAR
2026-02-034BRISTOL MYERS SQUIBB CO (BMY)Grant/award (A): 3,996.37 (derivative) @ $55.05EDGAR
2025-10-034Outlook Therapeutics, Inc. (OTLK)Grant/award (A): 286,734 (derivative) @ $0 · Grant/award (A): 58,648 (derivative) @ $0EDGAR
2025-02-044BRISTOL MYERS SQUIBB CO (BMY)Grant/award (A): 3,562.34 (derivative) @ $58.95EDGAR
2024-10-034Outlook Therapeutics, Inc. (OTLK)Grant/award (A): 56,636 (derivative) @ $0 · Grant/award (A): 47,232 (derivative) @ $0 · Grant/award (A): 12,082 (derivative) @ $0EDGAR
2024-03-084Outlook Therapeutics, Inc. (OTLK)Grant/award (A): 94,441 (derivative) @ $0EDGAR
2024-02-054BRISTOL MYERS SQUIBB CO (BMY)Grant/award (A): 4,314.77 (derivative) @ $48.67EDGAR
2024-01-034BRISTOL MYERS SQUIBB CO (BMY)Grant/award (A): 706.49 (derivative) @ $51.31EDGAR
2023-10-054Outlook Therapeutics, Inc. (OTLK)Grant/award (A): 210,225 (derivative) @ $0EDGAR
2023-10-034BRISTOL MYERS SQUIBB CO (BMY)Grant/award (A): 624.57 (derivative) @ $58.04EDGAR
2023-07-054BRISTOL MYERS SQUIBB CO (BMY)Grant/award (A): 553.94 (derivative) @ $63.95EDGAR
2023-04-044BRISTOL MYERS SQUIBB CO (BMY)Grant/award (A): 486.94 (derivative) @ $69.31EDGAR
2023-03-314Outlook Therapeutics, Inc. (OTLK)Grant/award (A): 41,065 (derivative) @ $0EDGAR
2023-02-034BRISTOL MYERS SQUIBB CO (BMY)Grant/award (A): 2,807.81 (derivative) @ $71.23EDGAR
2023-01-044BRISTOL MYERS SQUIBB CO (BMY)Grant/award (A): 469.08 (derivative) @ $71.95EDGAR
2022-10-074Outlook Therapeutics, Inc. (OTLK)Grant/award (A): 42,239 (derivative) @ $0EDGAR
2022-10-044BRISTOL MYERS SQUIBB CO (BMY)Grant/award (A): 474.75 (derivative) @ $71.09EDGAR
2022-08-154Outlook Therapeutics, Inc. (OTLK)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2022-07-054BRISTOL MYERS SQUIBB CO (BMY)Grant/award (A): 438.31 (derivative) @ $77EDGAR
2022-06-214EYENOVIA, INC. (EYEN)Grant/award (A): 22,222 @ $0 · Grant/award (A): 30,769 (derivative) @ $0EDGAR
2022-06-074BRISTOL MYERS SQUIBB CO (BMY)Option exercise (M): 2,949 @ $0 · Option exercise (M): 2,949 (derivative) @ $0EDGAR
2022-04-044BRISTOL MYERS SQUIBB CO (BMY)Grant/award (A): 462.14 (derivative) @ $73.03EDGAR
2022-02-034BRISTOL MYERS SQUIBB CO (BMY)Grant/award (A): 3,067.95 (derivative) @ $65.19EDGAR
2022-01-044BRISTOL MYERS SQUIBB CO (BMY)Grant/award (A): 521.25 (derivative) @ $62.35EDGAR
2021-11-224EYENOVIA, INC. (EYEN)Grant/award (A): 6,963 @ $0 · Grant/award (A): 9,653 (derivative) @ $0EDGAR
2021-10-014BRISTOL MYERS SQUIBB CO (BMY)Grant/award (A): 549.26 (derivative) @ $0EDGAR
2021-07-014BRISTOL MYERS SQUIBB CO (BMY)Grant/award (A): 487.00 (derivative) @ $0EDGAR
2021-06-144BRISTOL MYERS SQUIBB CO (BMY)Option exercise (M): 902 @ $0 · Option exercise (M): 902 (derivative) @ $0EDGAR
2021-06-044BRISTOL MYERS SQUIBB CO (BMY)Option exercise (M): 2,949 @ $0 · Option exercise (M): 2,949 (derivative) @ $0EDGAR
2021-04-024BRISTOL MYERS SQUIBB CO (BMY)Grant/award (A): 514.81 (derivative) @ $63.13EDGAR
2021-04-014EYENOVIA, INC. (EYEN)Grant/award (A): 1,223 @ $0 · Grant/award (A): 1,637 (derivative) @ $0EDGAR
2021-02-034BRISTOL MYERS SQUIBB CO (BMY)Grant/award (A): 3,054.17 (derivative) @ $62.21EDGAR
2021-01-054BRISTOL MYERS SQUIBB CO (BMY)Grant/award (A): 523.94 (derivative) @ $62.03EDGAR
2020-10-024BRISTOL MYERS SQUIBB CO (BMY)Grant/award (A): 539.06 (derivative) @ $60.29EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1656082 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs